药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ritodrine
Ondansetron
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Paliperidone.
Ritodrine
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Paliperidone.
Ritodrine
Ivosidenib
The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Paliperidone.
Ritodrine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Paliperidone.
Ritodrine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Paliperidone.
Ritodrine
Lorcainide
The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Paliperidone.
Ritodrine
Bunaftine
The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Paliperidone.
Ritodrine
Nizofenone
The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Paliperidone.
Ritodrine
Otilonium
The risk or severity of QTc prolongation can be increased when Otilonium is combined with Paliperidone.
Ritodrine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Paliperidone.
Ritodrine
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Paliperidone.
Ritodrine
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Paliperidone.
Ritodrine
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Paliperidone.
Ritodrine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Paliperidone.
Ritodrine
Simendan
The risk or severity of QTc prolongation can be increased when Simendan is combined with Paliperidone.
Ritodrine
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Paliperidone.
Ritodrine
Entinostat
The risk or severity of QTc prolongation can be increased when Entinostat is combined with Paliperidone.
Ritodrine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Paliperidone.
Ritodrine
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Paliperidone.
Ritodrine
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Paliperidone.